With Its Long History and Pioneering Spirit, Urology of Virginia Faces a Changing Landscape
Michael Fabrizio, MD, and Dana Adams, COO, provide their perspective on the challenges that urology practices face today.
Over the past few months, an alarming number of events have surfaced that we, as providers of oncologic urology care, should take notice.
PSA Recommendations Challenged After Analysis of PLCO Trial Data
During the annual American Urological
Association meeting leaders in
urology presented groundbreaking research,
new clinical guidelines, and the latest advances
in urologic medicine.
ADT Increases Risk for Depression in Elderly Men With Localized Prostate Cancer
Although androgen deprivation therapy has a survival benefit for patients with high-risk and locally advanced prostate cancer, it is associated with substantial safety concerns, and mixed data exist regarding whether it causes clinically significant depression.
High Genomic Classifier Score Increases Risk of Dying From Prostate Cancer
Results from a study using the Decipher Prostate Cancer Classifier noted that its use added very strong data about the likelihood of patients with prostate cancer dying within 10 years.
Dr Phillips on the Treatment Landscape for Patients With MCL
Dr Chari on the Bridging the Gaps in Hematologic Malignancies Meeting
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
2 Commerce Drive Cranbury, NJ 08512